Gene expression and matrix turnover in overused and damaged tendons

Scandinavian Journal of Medicine and Science in Sports

Volumn 15, Issue 4, 2005, Pages 241-251

  Riley, G P ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

ADAMTS; Aggrecanase; Matrix metalloproteinase; MMP

Indexed keywords

MATRIX METALLOPROTEINASE;

BIOMECHANICS; CHRONIC DISEASE; CONFERENCE PAPER; ENZYMOLOGY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; TENDON INJURY;

BIOMECHANICS; CHRONIC DISEASE; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMANS; MATRIX METALLOPROTEINASES; TENDON INJURIES;

EID: 22744454684     PISSN: 09057188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0838.2005.00456.x     Document Type: Conference Paper

References (106)

1. Abbaszade I, Liu RQ, Yang F, Rosenfeld SA, Ross OH, Link JR, Ellis DM, Tortorella MD, Pratta MA, Hollis JM, Wynn R, Duke JL, George HJ, Hillman MC Jr., Murphy K, Wiswall BH, Copeland RA, Decicco CP, Bruckner R, Nagase H, Itoh Y, Newton RC, Magolda RL, Trzaskos JM, Burn TC. Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem 1999: 274(33): 23443-23450.
2. Akeson WH, Amiel D, Abel MF, Garfin SR, Woo SL. Effects of immobilization enjoints. Clin Orthop 1987: 219: 28-37.
3. Alfredson H, Lorentzon M, Backman S, Backman A, Lerner UH. CDNA-arrays and real-time quantitative PCR techniques in the investigation of chronic achilles tendinosis. J Orthop Res 2003: 21(6): 970-975.
4. Amiel D, Gelberman RH, Harwood F, Siegel D. Fibronectin in healing flexor tendons subjected to immobilization or early controlled passive motion. Matrix 1991: 11: 184-189.
5. Archambault J, Tsuzaki M, Herzog W, Banes AJ. Stretch and interleukin-1beta induce matrix metalloproteinases in rabbit tendon cells in vitro. J Orthop Res 2002: 20(1): 36-39.
6. Åström M, Rausing A. Chronic achilles tendinopathy. A survey of surgical and histopathologic findings. Clin Orthop 1995: 316: 151-164.
7. Aumailley M, Gayraud B. Structure and biological activity of the extracellular matrix. J Mol Med 1998: 76: 253-265.
8. Bank RA, TeKoppele JM, Oostingh G, Hazleman BL, Riley GP. Lysylhydroxylation and non-reducible cross-linking of human supraspinatus tendon collagen: changes with age and in chronic rotator cuff tendinitis. Ann Rheum Dis 1999: 58: 35-41.
9. Banyard J, Bao L, Zetter BR. Type XXIII collagen, a new transmembrane collagen identified in metastatic tumor cells. J Biol Chem 2003: 278(23): 20989-20994.
10. Benjamin M. The structure and function of tendons. In: Hazleman BL, Riley GP, Speed CA. Soft tissue rheumatology. Oxford: Oxford University Press, 2004: 9-19.
11. Berenson MC, Blevins FT, Plaas AHK, Vogel KG. Proteoglycans of human rotator cuff tendons. J Orthop Res 1996: 14: 518-525.
12. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 1995: 7: 728-735.
13. Boot-Handford RP, Tuckwell DS, Plumb DA, Rock CF, Poulsom R. A novel and highly conserved collagen (Pro(Alpha)1(XXVII)) with a unique expression pattern and unusual molecular characteristics establishes a new clade within the vertebrate fibrillar collagen family. J Biol Chem 2003: 278(33): 31067-31077.
14. Brown PD. Clinical studies with matrix metalloproteinase inhibitors. Apmis 1999: 107(1): 174-180.
15. Cal S, Obaya AJ, Llamazares M, Garabaya C, Quesada V, Lopez-Otin C. Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains. Gene 2002: 283(1-2): 49-62.
16. Caterson B, Flannery CR, Hughes CE, Little CB. Mechanisms of proteoglycan metabolism that lead to cartilage destruction in the pathogenesis of arthritis. Drugs Today (Barc.) 1999: 35(4-5): 397-402.
17. Cawston TE. Proteinases and inhibitors. Br Med Bull 1995: 51: 385-401.
18. Cawston TE, Riley GP, Hazleman BL. Tendon lesions and soft tissue rheumatism - great outback or great opportunity. Ann Rheum Dis 1996: 55: 1-3.
19. Clark IM, Parker AE. Metalloproteinases: their role in arthritis and potential as therapeutic targets. Expert Opin Ther Targets 2003: 7(1): 19-34.
20. Colige A, Sieron AL, Li SW, Schwarze U, Petty E, Wertelecki W, Wilcox W, Krakow D, Cohn DH, Reardon W, Byers PH, Lapiere CM, Prockop DJ, Nusgens BV. Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene. Am J Hum Genet 1999: 65(2): 308-317.
21. Colige A, Vandenberghe I, Thiry M, Lambert CA, Van Beeumen J, Li SW, Prockop DJ, Lapiere CM, Nusgens BV. Cloning and characterization of ADAMTS-14, a novel ADAMTS displaying high homology with ADAMTS-2 and ADAMTS-3. J Biol Chem 2002: 277(8): 5756-5766.
22. Collins-Racie LA, Flannery CR, Zeng W, Corcoran C, Annis-Freeman B, Agostino MJ, Arai M, DiBlasio-Smith E, Dorner AJ, Georgiadis KE, Jin M, Tan XY, Morris EA, LaVallie ER. ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage. Matrix Biol 2004: 23(4): 219-230.
23. Corps AN, Harrall RL, Curry VA, Fenwick SA, Hazleman BL, Riley GP. Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1beta in human tendon-derived cells. A potential mechanism of fluoroquinolone-induced tendinopathy. Arthritis Rheum 2002: 46: 3034-3040.
24. Corps AN, Robinson AH, Movin T, Costa ML, Ireland DC, Hazleman BL, Riley GP. Versican splice variant messenger RNA expression in normal human achilles tendon and tendinopathies. Rheumatology 2004: 43: 969-972.
25. Creemers LB, Jansen IDC, Docherty AJP, Reynolds JJ, Beertsen W, Everts V. Gelatinase A (MMP-2) and cysteine proteinases are essential for the degradation of collagen in soft connective tissue. Matrix Biol 1998: 17: 35-46.
26. Curwin SL, Vailas AC, Wood J. Immature tendon adaptation to strenuous exercise. J Appl Physiol 1988: 65: 2297-2301.
27. Dalton S, Cawston TE, Riley GP, Bayley IJL, Hazleman BL. Human shoulder tendon biopsy samples in organ culture produce procollagenase and tissue inhibitor of metalloproteinases. Ann Rheum Dis 1995: 54: 571-577.
28. Dickinson SC, Vankemmelbeke MN, Buttle DJ, Rosenberg K, Heinegard D, Hollander AP. Cleavage of cartilage oligomeric matrix protein (thrombospondin-5) by matrix metalloproteinases and a disintegrin and metalloproteinase with thrombospondin motifs. Matrix Biol 2003: 22(3): 267-278.
29. Eriksen HA, Pajala A, Leppilahti J, Risteli J. Increased content of type III collagen at the rupture site of human achilles tendon. J Orthop Res 2002: 20(6): 1352-1357.
30. Everts V, Van der Zee E, Creemers L, Beertsen W. Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling. Histochem J 1996: 28: 229-245.
31. Fernandes RJ, Hirohata S, Engle JM, Colige A, Cohn DH, Eyre DR, Apte SS. Procollagen II amino propeptide processing by ADAMTS-3. Insights on dermatosparaxis. J Biol Chem 2001: 276(34): 31502-31509.
32. Fitzgerald J, Bateman JF. A new FACIT of the collagen family: COL21A1. FEBS Lett 2001: 505(2): 275-280.
33. Flannery CR, Zeng W, Corcoran C, Collins-Racie LA, Chockalingam PS, Hebert T, Mackie SA, McDonagh T, Crawford TK, Tomkinson KN, LaVallie ER, Morris EA. Autocatalytic cleavage of ADAMTS-4 (aggrecanase-1) reveals multiple glycosaminoglycan-binding sites. J Biol Chem 2002: 277(45): 42775-42780.
34. Fukuta S, Oyama M, Kavalkovich K, Fu FH, Niyibizi C. Identification of types II, IX and X collagens at the insertion site of the bovine achilles tendon. Matrix Biol 1998: 17: 65-73.
35. Gao G, Plaas AH, Thompson VP, Jin S, Zuo F, Sandy JD. ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by GPI-anchored MT4-MMP and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1. J Biol Chem 2004: 279(11): 10042-10051.
36. Gelberman RH, Amiel D, Gonsalves M, Woo SLY, Akeson WH. The influence of protected passive mobilization on the healing of flexor tendons: a biochemical and microangiographic study. Hand 1981: 13(2): 120-128.
37. Gillard GC, Reilly HC, Bell-Booth PG, Flint MH. The influence of mechanical forces on the glycosaminoglycan content of the rabbit flexor digitorum profundus tendon. Conn Tiss Res 1979: 7: 37-46.
38. Gotoh M, Hamada K, Yamakawa H, Tomonaga A, Inoue A, Fukuda HO. Significance of granulation tissue in torn supraspinatus insertions: an immunohistochemical study with antibodies against interleukin-1b, cathepsin D, and matrix metalloprotease- 1. J Orthop Res 1997: 15: 33-39.
39. Hannafin JA. Effect of stress deprivation and cyclic tensile loading on the material and morphologic properties of canine flexor digitorum profundus tendon: an in vitro study. J Orthop Res 1995: 13: 907-914.
40. Hardingham TE, Fosang AJ. Proteoglycans: many forms and many functions. FASEB J 1992: 6: 861-870.
41. Hashimoto T, Wakabayashi T, Watanabe A, Kowa H, Hosoda R, Nakamura A, Kanazawa I, Arai T, Takio K, Mann DM, Iwatsubo T. CLAC: a Novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC-P/collagen type XXV. EMBO J 2002: 21(7): 1524-1534.
42. Heinemeier K, Langberg H, Olesen JL, Kjaer M. Role of TGF-beta1 in relation to exercise-induced type I collagen synthesis in human tendinous tissue. J Appl Physiol 2003: 95(6): 2390-2397.
43. Ireland D, Harrall RL, Holloway G, Hackney R, Hazleman BL, Riley GP. Multiple changes in gene expression in chronic human achilles tendinopathy. Matrix Biol 2001: 20(3): 159-169.
44. Jarvinen M, Józsa L, Kannus P, Jarvinen TLN, Kvist M, Leadbetter W. Histopathological findings in chronic tendon disorders. Scand J Med Sci Sports 1997: 7(2): 86-95.
45. Józsa L, Kannus P. Overuse injuries of tendons. In: Józsa L, Kannus P.. Human tendons: anatomy, physiology and pathology, 1st edn. Champaign, IL: Human Kinetics, 1997a: 164-253.
46. Józsa L, Kannus P. Structure and metabolism of normal tendons. In: Józsa L, Kannus P. Human tendons. Anatomy physiology and pathology, 1st edn. Champaign, IL: Human Kinetics, 1997b: 46-95.
47. Kannus P. Tendon pathology: basic science and clinical applications. Sports Exerc Injury 1997: 3(2): 62-75.
48. Kannus P. Structure of the tendon connective tissue. Scand J Med Sci Sports 2000: 10(6): 312-320.
49. Kannus P, Józsa L. Histopathological changes preceding spontaneous rupture of a tendon. A controlled study of 891 patients. J Bone Joint Surg [Am] 1991: 73-A: 1507-1525.
50. Kashiwagi M, Enghild JJ, Gendron C, Hughes C, Caterson B, Itoh Y, Nagase H. Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J Biol Chem 2004: 279(11): 10109-10119.
51. Kashiwagi M, Tortorella M, Nagase H, Brew K. TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J Biol Chem 2001: 276(16): 12501-12504.
52. Kaushal GP, Shah SV. The new kids on the block: ADAMTSs, potentially multifunctional metalloproteinases of the ADAM family. J Clin Invest 2000: 105(10): 1335-1337.
53. Kjaer M, Langberg H, Skovgaard D, Olesen J, Bulow J, Krogsgaard M, Boushel R. In vivo studies of peritendinous tissue in exercise. Scand J Med Sci Sports 2000: 10(6): 326-331.
54. Koch M, Foley JE, Hahn R, Zhou P, Burgeson RE, Gerecke DR, Gordon MK. Alpha 1(Xx) collagen, a new member of the collagen subfamily, fibril- associated collagens with interrupted triple helices. J Biol Chem 2001: 276(25): 23120-23126.
55. Koch M, Laub F, Zhou P, Hahn RA, Tanaka S, Burgeson RE, Gerecke DR, Ramirez F, Gordon MK. Collagen XXIV, a vertebrate fibrillar collagen with structural features of invertebrate collagens: selective expression in developing cornea and bone. J Biol Chem 2003: 278(44): 43236-43244.
56. Koshy PJ, Lundy CJ, Rowan AD, Porter S, Edwards DR, Hogan A, Clark IM, Cawston TE. The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction. Arthritis Rheum 2002: 46(4): 961-967.
57. Koskinen SO, Heinemeier KM, Olesen JL, Langberg H, Kjaer M. Physical exercise can influence local levels of matrix metalloproteinases and their inhibitors in tendon-related connective tissue. J Appl Physiol 2004: 96(3): 861-864.
58. Kuno K, Okada Y, Kawashima H, Nakamura H, Miyasaka M, Ohno H, Matsushima K. ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan. FEBS Lett 2000: 478(3): 241-245.
59. Langberg H, Bulow J, Kjaer M. Blood flow in the peritendinous space of the human achilles tendon during exercise. Acta Physiol Scand 1998: 163(2): 149-153.
60. Langberg H, Rosendal L, Kjaer M. Training-induced changes in peritendinous type I collagen turnover determined by microdialysis in humans. J Physiol 2001: 534(Part 1): 297-302.
61. Langberg H, Skovgaard D, Karamouzis M, Bulow J, Kjaer M. Metabolism and inflammatory mediators in the peritendinous space measured by microdialysis during intermittent isometric exercise in humans. J Physiol 1999: 515(Part 3): 919-927.
62. Leadbetter WB. Cell-matrix response in tendon injury. Clin Sports Med 1992: 11: 533-578.
63. Lehto M, Józsa L, Kvist M, Jarvinen M, Balint BJ, Reffy A. Fibronectin in the ruptured human achilles tendon and its paratenon an immunoperoxidase study. Ann Chir Gynaecol 1990: 79(2): 72-77.
64. Mackie EJ, Halfter W, Liverani D. Induction of tenascin in healing wounds. J Cell Biol 1988: 107(6, Part 2): 2757-2767.
65. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. TIG 1990: 6: 121-125.
66. McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore! curr. Opin Cell Biol 2001: 13(5): 534-540.
67. McNeilly CM, Banes AJ, Benjamin M, Ralphs JR. Tendon cells in vivo form a three dimensional network of cell processes linked by gap junctions. J Anat 1996: 189: 593-600.
68. Murphy G, Willenbrock F. Tissue inhibitors of matrix metalloendopeptidases. Methods Enzymol 1995: 248: 496-510.
69. Murphy G, Willenbrock F, Crabbe T, O'Shea M, Ward R, Atkinson S, O'Connell J, Docherty A. Regulation of matrix metalloproteinase activity. Ann N Y Acad Sci 1994: 732: 31-41.
70. Myllyharju J, Kivirikko KI. Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet 2004: 20(1): 33-43.
71. Nagase H. Matrix metalloproteinases. A mini-review. Contrib Nephrol 1994: 107: 85-93.
72. Pace JM, Corrado M, Missero C, Byers PH. Identification, characterization and expression analysis of a new fibrillar collagen gene, COL27A1. Matrix Biol 2003: 22(1): 3-14.
73. Patterson-Kane JC, Wilson AM, Firth EC, Parry DAD, Goodship AE. Comparison of collagen fibril populations in the superficial digital flexor tendons of exercised and nonexercised thoroughbreds. Equine Vet J 1997: 29: 121-125.
74. Pierfitte C, Royer RJ. Tendon disorders with fluoroquinolones. Therapie 1996: 51: 419-420.
75. Rees SG, Flannery CR, Little CB, Hughes CE, Caterson B, Dent CM. Catabolism of aggrecan, decorin and biglycan in tendon. Biochem J 2000: 350(Part 1): 181-188.
76. Riley G. The pathogenesis of tendinopathy. A molecular perspective. Rheumatology (Oxford) 2004a: 43(2): 131-142.
77. Riley GP. Tendon and ligament biochemistry and pathology. In: Hazleman BL, Riley GP, Speed CA. Soft tissue rheumatology. Oxford: Oxford University Press, 2004b: 20-53.
78. Riley GP, Curry V, DeGroot J, van El B, Verzijl N, TeKoppele JM, Hazleman BL, Bank RA. Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology. Matrix Biol 2002: 21(2): 185-195.
79. Riley GP, Harrall RL, Constant CR, Cawston TE, Hazleman BL. Prevalence and possible pathological significance of calcium phosphate salt accumulation in tendon matrix degeneration. Ann Rheum Dis 1996a: 55: 109-115.
80. Riley GP, Harrall RL, Cawston TE, Hazleman BL, Mackie EJ. Tenascin-C and human tendon degeneration. Am J Pathol 1996b: 149: 933-943.
81. Riley GP, Harrall RL, Constant CR, Chard MD, Cawston TE, Hazleman BL. Tendon degeneration and chronic shoulder pain: changes in the collagen composition of the human rotator cuff tendons in rotator cuff tendinitis. Ann Rheum Dis 1994a: 53: 359-366.
82. Riley GP, Harrall RL, Constant CR, Chard MD, Cawston TE, Hazleman BL. Glycosaminoglycans of human rotator cuff tendons: changes with age and in chronic rotator cuff tendinitis. Ann Rheum Dis 1994b: 53: 367-376.
83. Samiric T, Ilic MZ, Handley CJ. Characterisation of proteoglycans and their catabolic products in tendon and explant cultures of tendon. Matrix Biol 2004a: 23(2): 127-140.
84. Samiric T, Ilic MZ, Handley CJ. Large aggregating and small leucine-rich proteoglycans are degraded by different pathways and at different rates in tendon. Eur J Biochem 2004b: 271(17): 3612-3620.
85. Sandy JD, Flannery CR, Neame PJ, Lohmander LS. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. J Clin Invest 1992: 89: 1512-1516.
86. Sandy JD, Neame PJ, Boynton RE, Flannery CR. Catabolism of aggrecan in cartilage explants, identification of a major cleavage site within the interglobular domain. J Biol Chem 1991: 266(14): 8683-8685.
87. Sandy JD, Westling J, Kenagy RD, Iruela-Arispe ML, Verscharen C, Rodriguez-Mazaneque JC, Zimmermann DR, Lemire JM, Fischer JW, Wight TN, Clowes AW. Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS- 4. J Biol Chem 2001: 276(16): 13372-13378.
88. Sato K, Yomogida K, Wada T, Yorihuzi T, Nishimune Y, Hosokawa N, Nagata K. Type XXVI collagen, a new member of the collagen family, is specifically expressed in the testis and ovary. J Biol Chem 2002: 277(40): 37678-37684.
89. Smith RK, Birch H, Patterson-Kane J, Firth EC, Williams L, Cherdchutham W, van Weeren WR, Goodship AE. Should equine athletes commence training during skeletal development?: changes in tendon matrix associated with development, ageing, function and exercise. Equine Vet J 1999: 30(Suppl): 201-209.
90. Smith RK, Birch HL, Goodman S, Heinegard D, Goodship AE. The influence of ageing and exercise on tendon growth and degeneration-hypotheses for the initiation and prevention of strain-induced tendinopathies. Comp Biochem Physiol A Mol Integr Physiol 2002: 133(4): 1039-1050.
91. Somerville RP, Longpre JM, Jungers KA, Engle JM, Ross M, Evanko S, Wight TN, Leduc R, Apte SS. Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1. J Biol Chem 2003: 278(11): 9503-9513.
92. Tipton CM, Vailas AC, Matthes RD. Experimental studies on the influences of physical activity on ligaments, tendons and joints. Acta Med Scand 1986: 711: 157-168.
93. Tortorella MD, Burn TC, Pratta MA, Abbaszade I, Hollis JM, Liu R, Rosenfeld SA, Copeland RA, Decicco CP, Wynn R, Rockwell A, Yang F, Duke JL, Solomon K, George H, Bruckner R, Nagase H, Itoh Y, Ellis DM, Ross H, Wiswall BH, Murphy K, Hillman MC Jr., Hollis GF, Arner EC. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 1999: 284(5420): 1664-1666.
94. Tortorella MD, Malfait AM, Deccico C, Arner E. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage 2001: 9(6): 539-552.
95. Tsuzaki M, Bynum D, Almekinders L, Yang X, Faber J, Banes AJ. ATP modulates load-inducible IL-1beta, COX 2, and MMP-3 gene expression in human tendon cells. J Cell Biochem 2003a: 89(3): 556-562.
96. Tsuzaki M, Guyton G, Garrett W, Archambault JM, Herzog W, Almekinders L, Bynum D, Yang X, Banes AJ. IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J Orthop Res 2003b: 21(2): 256-264.
97. Vankemmelbeke MN, Holen I, Wilson AG, Ilic MZ, Handley CJ, Kelner GS, Clark M, Liu C, Maki RA, Burnett D, Buttle DJ. Expression and activity of ADAMTS-5 in synovium. Eur J Biochem 2001: 268(5): 1259-1268.
98. Vogel KG, Koob TJ. Structural specialisation in tendons under compression. Int Rev Cytol 1989: 115: 267-293.
99. Waggett AD, Ralphs JR, Kwan APL, Woodnutt D, Benjamin M. Characterization of collagens and proteoglycans at the insertion of the human achilles tendon. Matrix Biol 1998: 16: 457-470.
100. Wang P, Tortorella M, England K, Malfait AM, Thomas G, Arner L, Pei D. Proprotein convertase furin interacts with and cleaves Pro-ADAMTS4 (aggrecanase-1) in the trans-Golgi network. J Biol Chem 2004: 279(15): 15434-15440.
101. Woo SLY, Gomez MA, Amiel D, Ritter MA, Gelberman RH, Akeson WH. The effects of exercise on the biomechanical and biochemical properties of swine digital flexor tendons. J Biomech Eng 1981: 103: 51-56.
102. Woo SLY, Gomez MA, Sites TJ, Newton PO, Orlando CA, Akeson WH. The biomechanical and morphological changes in the medial collateral ligament of the rabbit after immobilization and remobilization. J Bone Joint Surg Am 1987: 69(8): 1200-1211.
103. Woo SLY, Gomez MA, Woo Y-K, Akeson WH. Mechanical properties of tendons and ligaments: II. The relationships of immobilization and exercise on tissue remodeling. Biorheology 1982: 19: 397-408.
104. Yamaji N, Nishimura K, Abe K, Ohara O, Nagase T, Nomura N. Novel metalloproteinase having aggrecanase activity. European Patent 00974894.8. 11-10-2000.
105. Yasuda K, Hayashi K. Changes in biomechanical properties of tendons and ligaments from joint disuse. Osteoarthritis Cartilage 1999: 7(1): 122-129.
106. Yoshihara Y, Hamada K, Nakajima T, Fujikawa K, Fukuda H. Biochemical markers in the synovial fluid of glenohumeral joints from patients with rotator cuff tear. J Orthop Res 2001: 19(4): 573-579.